Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
21.46
+0.10 (0.47%)
At close: Sep 26, 2025, 4:00 PM EDT
21.36
-0.10 (-0.47%)
After-hours: Sep 26, 2025, 7:34 PM EDT
Progyny Revenue
Progyny had revenue of $332.87M in the quarter ending June 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to $1.24B, up 9.62% year-over-year. In the year 2024, Progyny had annual revenue of $1.17B with 7.22% growth.
Revenue (ttm)
$1.24B
Revenue Growth
+9.62%
P/S Ratio
1.50
Revenue / Employee
$1,826,424
Employees
680
Market Cap
1.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.17B | 78.62M | 7.22% |
Dec 31, 2023 | 1.09B | 301.69M | 38.34% |
Dec 31, 2022 | 786.91M | 286.29M | 57.19% |
Dec 31, 2021 | 500.62M | 155.76M | 45.17% |
Dec 31, 2020 | 344.86M | 115.18M | 50.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PGNY News
- 18 days ago - Progyny's Strong Fundamentals & Global Growth: Why I Choose To BUY - Seeking Alpha
- 7 weeks ago - Progyny, Inc. (PGNY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Progyny, Inc. Announces Second Quarter 2025 Results - GlobeNewsWire
- 2 months ago - New Progyny Study Reveals Gap Between Perceptions and Realities in Women's Health Benefits Coverage - GlobeNewsWire
- 2 months ago - Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause - GlobeNewsWire
- 2 months ago - Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report - GlobeNewsWire
- 3 months ago - Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's Health - GlobeNewsWire
- 3 months ago - Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution - GlobeNewsWire